Esperion Therapeutics, Inc. (ESPR)

The Esperion ... Bempedoic acid, an ACL-Inhibiting Regimen) Outcomes subgroup analyses as poster presentations at the 2024 American College of Cardiology’s Annual Scientific Session (ACC. Read More

FDA Approval Broadens Eligibility for Treatment With Nexletol, Nexlizet

Credit: Esperion. The approval was based on data from the ... the approval of Nexletol ® (bempedoic acid 180mg tablets) and Nexlizet ® (bempedoic acid 180mg and ezetimibe 10mg tablets) to ... Read More

Esperion stock jumps as non-statin therapy shows clinical benefits across diverse patient groups

Esperion Therapeutics (NASDAQ:ESPR) shares gained 7% premarket on Monday after the company touted clinical benefits of NEXLETOL (bempedoic acid) tablets in diverse populations, including women ... Read More

Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting

April 12, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that preclinical and clinical data ... press release, including statements related to Ultragenyx's ... Read More

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

DUBLIN, Ireland and BRIDGEWATER, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted three data presentations at ACC ... acid (EA; 20:0) and Trolox ... Read More

Nexletol side effects: What you should know

Nexletol (bempedoic acid) is a brand-name oral tablet that’s prescribed for high cholesterol ... We link primary sources — including studies, scientific references, and statistics — within ... Read More

Apollomics Announces Poster Presentations of Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Vebreltinib is a potent, small molecule, orally bioavailable, brain penetrating and highly selective c-MET inhibitor. It works by inhibiting the aberrant activation of the HGF/c-MET axis, a key ... Read More

SK Life Science Announces Data Presentations for XCOPRI® (cenobamate tablets) CV at the 2024 American Academy of Neurology Annual Meeting

The data includes a study examining the relative bioavailability of cenobamate as an intact or crushed tablet administered ... of real-world data on the use of cenobamate in the U.S. and globally." ... Read More

Dog Company Announces New Air Travel Experience Designed Specifically for Canines: They 'Will Be the VIPs'

the "world’s first air travel experience designed specifically for dogs first, and their human companions second," according to a press release obtained by PEOPLE. Currently, routes will serve ... Read More

Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC

Data reported today highlight the potential of TARA-002 in patients with NMIBC. Data were derived from three ... s filings and reports with the United States Securities and Exchange Commission. All ... Read More

Neo-Concept International Group Holdings Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq

Loeb & Loeb LLP is acting as U.S. legal counsel to the Company and Hunter Taubman Fischer & Li LLC is acting as legal counsel to the Underwriters for the Offering. This press release has been ... in ... Read More